---
figid: PMC3577828__pone.0056258.g006
figtitle: Jejunal Proteins Secreted by db/db Mice or Insulin-Resistant Humans Impair
  the Insulin Signaling and Determine Insulin Resistance
organisms:
- NA
pmcid: PMC3577828
filename: pone.0056258.g006.jpg
figlink: /pmc/articles/PMC3577828/figure/pone-0056258-g006/
number: F6
caption: Upon insulin binding insulin receptor activates, through insulin receptor
  substrate 1 (IRS1), phosphatidylinositol-3-kinase (PI3K), which results in Akt phosphorylation
  at 308Thr residue via Phosphatidylinositol 4,5-bisphosphate (PIP2) to Phosphatidylinositol
  3,4,5-bisphosphate (PIP3) conversion followed by Akt and PDK1 recruitment to plasma
  membrane (not shown). A factor J present in duodenal-jejunal conditioned medium
  activates, possibly via the tuberous sclerosis complex TSC1-TSC2, the mammlian target
  of rapamycin complex 2 (mTORC2). mTORC2 also appears to be regulated by the PI3K
  pathway and phosphorylates Akt at 473Ser residue. Through TSC1-TSC2 and the GTPase
  Rheb, Akt activates mTORC1 and its direct substrate S6K1. Akt also inhibits GSK3.
  S6K1, mTORC1 and GSK3 phosphorylate serine residues on IRS1, thus attenuating insulin
  signalling. Hypothetical signalling is denoted by dotted lines.
papertitle: Jejunal Proteins Secreted by db/db Mice or Insulin-Resistant Humans Impair
  the Insulin Signaling and Determine Insulin Resistance.
reftext: Serenella Salinari, et al. PLoS One. 2013;8(2):e56258.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.947081
figid_alias: PMC3577828__F6
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3577828__F6
ndex: 2669860f-dec3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3577828__pone.0056258.g006.html
  '@type': Dataset
  description: Upon insulin binding insulin receptor activates, through insulin receptor
    substrate 1 (IRS1), phosphatidylinositol-3-kinase (PI3K), which results in Akt
    phosphorylation at 308Thr residue via Phosphatidylinositol 4,5-bisphosphate (PIP2)
    to Phosphatidylinositol 3,4,5-bisphosphate (PIP3) conversion followed by Akt and
    PDK1 recruitment to plasma membrane (not shown). A factor J present in duodenal-jejunal
    conditioned medium activates, possibly via the tuberous sclerosis complex TSC1-TSC2,
    the mammlian target of rapamycin complex 2 (mTORC2). mTORC2 also appears to be
    regulated by the PI3K pathway and phosphorylates Akt at 473Ser residue. Through
    TSC1-TSC2 and the GTPase Rheb, Akt activates mTORC1 and its direct substrate S6K1.
    Akt also inhibits GSK3. S6K1, mTORC1 and GSK3 phosphorylate serine residues on
    IRS1, thus attenuating insulin signalling. Hypothetical signalling is denoted
    by dotted lines.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRS1
  - TSC2
  - TSC1
  - CCL26
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - AKT1
  - AKT2
  - AKT3
  - RHEB
  - RHEBP1
  - MTG1
  - GSK3A
  - GSK3B
  - RPTOR
  - RPS6KB1
  - Ser
  - Rapamycin
---
